488 results on '"Richie, Thomas L."'
Search Results
2. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine
3. Implementation of a Randomized, Placebo-Controlled Trial of Live Attenuated Malaria Sporozoite Vaccines in an Indonesian Military Study Population
4. Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa
5. Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial Guinea
6. A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection
7. PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial
8. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial
9. Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial
10. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults
11. Protection from Malaria after Pre-Conception PfSPZ Vaccine
12. OA-722 Assessment of naturally acquired humoral immunity against malaria protecting against controlled human malaria infection (CHMI)
13. Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity
14. Piloting delivery of PfSPZ vaccines for malaria through a cryogenic vaccine cold chain to travel and military medicine clinics.
15. Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial Guinea
16. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
17. Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults
18. Mefloquine Is Highly Efficacious against Chloroquine-Resistant Plasmodium vivax Malaria and Plasmodium falciparum Malaria in Papua, Indonesia
19. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
20. Plasmodium 18S rRNA biomarker clearance after FDA-approved antimalarial treatment in controlled human malaria infection trials
21. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
22. Induction of CD4 + T Cell-Dependent CD8 + Type 1 Responses in Humans by a Malaria DNA Vaccine
23. Malaria Prophylaxis Using Azithromycin: A Double-Blind, Placebo-Controlled Trial in Irian Jaya, Indonesia
24. PfSPZ Vaccine Does Not Increase Biomarkers of Epstein-Barr Virus Reactivation Predictive of Endemic Burkitt Lymphoma
25. A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria
26. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
27. The march toward malaria vaccines
28. Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy
29. Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
30. Plasmodium 18S Ribosomal RNA Biomarker Clearance After Food and Drug Administration–Approved Antimalarial Treatment in Controlled Human Malaria Infection Trials.
31. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination
32. The impact of Loa loa microfilaraemia on research subject retention during a whole sporozoite malaria vaccine trial in Equatorial Guinea
33. Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean Adults
34. Use of Adenovirus Serotype 5 Vaccine Vectors in Seropositive, Uncircumcised Men: Safety Lessons from the Step Trial
35. Additional file 1 of Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial Guinea
36. Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
37. Sporozoite immunization: innovative translational science to support the fight against malaria.
38. A First for Human Vaccinology: GMP Compliant Radiation Attenuation of Plasmodium falciparum Sporozoites for Production of a Vaccine Against Malaria
39. Genome, proteome, and immunome data explain why 6 month controlled human malaria infection with sporozoites of the Pf7G8 clone of Plasmodium falciparum is a rigorous predictor of the efficacy of the PfNF54-based PfSPZ Vaccine in Africa
40. Acquisition of Invasion-Inhibitory Antibodies Specific for the 19-kDa Fragment of Merozoite Surface Protein 1 in a Transmigrant Population Requires Multiple Infections
41. Protective immunity to pre-erythrocytic stage malaria
42. Safety and Clinical Outcome of Experimental Challenge of Human Volunteers with Plasmodium falciparum-Infected Mosquitoes: An Update
43. Diagnostic Performance and Comparison of Ultrasensitive and Conventional Rapid Diagnostic Test, Thick Blood Smear and Quantitative PCR for Detection of Low-Density Plasmodium Falciparum Infections During a Controlled Human Malaria Infection Study in Equatorial Guinea
44. A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
45. Empowering malaria vaccination by drug administration
46. Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection
47. Protection of Humans against Malaria by Immunization with Radiation-Attenuated Plasmodium falciparum Sporozoites
48. IMRAS—Immunization with radiation-attenuated Plasmodium falciparum sporozoites by mosquito bite: Cellular immunity to sporozoites, CSP, AMA1, TRAP and CelTOS
49. Beyond Blood Smears: Qualification of Plasmodium 18S rRNA as a Biomarker for Controlled Human Malaria Infections
50. Functional immunoassays using an in-vitro malaria liver-stage infection model: where do we go from here?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.